Synthesis and biological evaluation of novel 1-substituted 3-(3-phenoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors

被引：12
|
作者：
Zheng, Nan [1 ,2 ]
Hao, Qun [1 ]
Lin, Kuaile [1 ]
Pan, Jing [1 ,2 ]
Li, Yingxia [2 ]
Zhou, Weicheng [1 ]
机构：
[1] China State Inst Pharmaceut Ind, Shanghai Key Lab Antiinfect, State Key Lab New Drug & Pharmaceut Proc, Shanghai Inst Pharmaceut Ind, 285 Gebaini Rd, Shanghai 201203, Peoples R China
[2] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 02期
关键词：
BTK inhibitors; 1-Substituted pyrazolo[3,4-d]pyrimidine; Inhibitory activity; B-cell lymphoblastic leukemia; Cytotoxicity; B-CELL; DISCOVERY; IBRUTINIB;
D O I：
10.1016/j.bmcl.2018.11.051
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new series of 1-substituted pyrazolopyrimidine derivatives were synthesized as potent BTK inhibitors and they were evaluated by enzyme-based assay and anti-proliferation against multiple B-cell lymphoma cell lines in vitro. Among these compounds, 9h exhibited the highest potency against BTK enzyme, with IC50 value of 4.2 nM. In particular, 8 and 9f performed better inhibition against the proliferation of B lymphoma cell lines DOHH2 and WSU-DLCL2 than the clinical drug ibrutinb. In addition, the test toward the normal PBMC cells showed that 8 possessed low cell cytotoxicity. All these explorations indicated that 8 could serve as a valuable anti-tumor agent for B-cell lymphoblastic leukemia treatment.
引用
收藏
页码：225 / 229
页数：5
相关论文
共 50 条
  • [21] Discovery and biological evaluation of N-(3-(7-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2H-pyrimido[4,5-d][1,3]oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton's tyrosine kinase inhibitors
    Lai, Meng-zhen
    Song, Pei-ran
    Dou, Dou
    Diao, Yan-yan
    Tong, Lin-jiang
    Zhang, Tao
    Xie, Hua
    Li, Hong-lin
    Ding, Jian
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (03) : 415 - 422
  • [22] Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
    Wang, Aoli
    Li, Xixiang
    Chen, Cheng
    Wu, Hong
    Qi, Ziping
    Hu, Chen
    Yu, Kailin
    Wu, Jiaxin
    Liu, Juan
    Liu, Xiaochuan
    Hu, Zhenquan
    Wang, Wei
    Wang, Wenliang
    Wang, Wenchao
    Wang, Li
    Wang, Beilei
    Liu, Qingwang
    Li, Lili
    Ge, Jian
    Ren, Tao
    Zhang, Shanchun
    Xia, Ruixiang
    Liu, Jing
    Liu, Qingsong
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (20) : 8407 - 8424
  • [23] Design and Synthesis of Novel 3-(2-Aminopyridin-3-yl)-1,2,4-Triazolo [4,3-b]Pyridazine Derivatives as a Reversible Bruton's Tyrosine Kinase Inhibitors
    Park, Chi Hoon
    Kim, Dukwoon
    Jung, Hyeonseok
    Jeon, Jeong Hee
    Achary, Raghavendra
    Lee, Joo-Youn
    Kim, Pilho
    Jung, Heejung
    Hwang, Jong Yeon
    Ryu, Do Hyun
    Du Ha, Jae
    Cho, Sung Yun
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2018, 39 (07): : 853 - 857
  • [24] Design, synthesis and evaluation of novel 5-phenylpyridin-2(1H)-one derivatives as potent reversible Bruton's tyrosine kinase inhibitors
    Zhao, Xinge
    Xin, Minhang
    Huang, Wei
    Ren, Yanliang
    Jin, Qiu
    Tang, Feng
    Jiang, Hailong
    Wang, Yazhou
    Yang, Jie
    Mo, Shifu
    Xiang, Hua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (02) : 348 - 364
  • [25] Synthesis of Novel Pyrido[2′,3′:3,4]Pyrazolo[1,5-α]Quinazoline Derivatives, Their Biological Evaluation and Molecular Modelling Studies
    Kumar, Nagiri Ravi
    Swaroop, Desireddy Krishna
    Punna, Nagender
    Sirisha, Kanugala
    Ganapathi, Thipparapu
    Kumar, Chityal Ganesh
    Narsaiah, Banda
    CHEMISTRYSELECT, 2018, 3 (27): : 7813 - 7821
  • [26] Discovery of orally available 1 H-pyrazolo [3, 4- d ] pyrimidin-4-amine derivative as a novel BTK inhibitor
    Wang, Zunyuan
    Wang, Shu
    Chai, Jiaze
    Chi, Xinglong
    Ying, Jiaxun
    Kang, Youkun
    Pan, Youlu
    Zeng, Shenxin
    Ma, Zhen
    Wang, Wenyong
    Huang, Wenhai
    ARABIAN JOURNAL OF CHEMISTRY, 2024, 17 (09)
  • [27] Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors
    Liu, Na
    Wang, Yanfen
    Huang, Gongchao
    Ji, Conghui
    Fan, Wei
    Li, Haitao
    Cheng, Ying
    Tian, Hongqi
    BIOORGANIC CHEMISTRY, 2016, 65 : 146 - 158
  • [28] Design and synthesis of 1H-pyrazolo[3,4-c]pyridine derivatives as a novel structural class of potent GPR119 agonists
    Matsuda, Daisuke
    Kobashi, Yohei
    Mikami, Ayako
    Kawamura, Madoka
    Shiozawa, Fumiyasu
    Kawabe, Kenichi
    Hamada, Makoto
    Oda, Koji
    Nishimoto, Shinichi
    Kimura, Kayo
    Miyoshi, Masako
    Takayama, Noriko
    Kakinuma, Hiroyuki
    Ohtake, Norikazu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (15) : 3441 - 3446
  • [29] Design, synthesis and biological evaluation of N-(3-(1H-tetrazol-1-yl)phenyl)isonicotinamide derivatives as novel xanthine oxidase inhibitors
    Zhang, Ting-jian
    Zhang, Yi
    Tu, Shun
    Wu, Yu-hang
    Zhang, Zhen-hao
    Meng, Fan-hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
  • [30] Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation
    Gao, Jun
    Zhang, Zhaofeng
    Zhang, Bing
    Mao, Qing
    Dai, Xiwen
    Zou, Qian
    Lei, Yu
    Feng, Yao
    Wang, Shaojie
    BIOORGANIC CHEMISTRY, 2020, 95
12345